Trump Administration Sets Favorable Medicare Advantage Rates, Boosting Health Insurers

• The final 2.48% payment increase is nearly 28 times larger than the 0.09% rate initially proposed in January, representing a major policy reversal
• Health insurer stocks surged in after-hours trading: Humana up 12%, UnitedHealth and CVS both up over 9%
• More than half of Medicare beneficiaries are enrolled in Medicare Advantage plans, making this rate decision critical for both insurers' profitability and beneficiary coverage options

Summary: Trump Administration Increases Medicare Advantage Rates, Health Insurers Rally

Key Developments

The Trump administration finalized a 2.48% increase in Medicare Advantage payments for 2027, totaling over $13 billion in additional funding. This represents a significant improvement from the 0.09% rate hike initially proposed in January by the Centers for Medicare & Medicaid Services (CMS).

Market Impact

Health insurer stocks surged in after-hours trading following the announcement:

• Humana rose more than 9%
• CVS Health jumped approximately 12%
• UnitedHealth also experienced gains

The dramatic reversal from the proposed rate came after the January announcement had severely pressured these stocks.

Company and Sector Context

Medicare Advantage refers to privately run health insurance plans contracted through Medicare. Currently, more than half of Medicare beneficiaries are enrolled in these plans, attracted by lower monthly premiums and additional benefits not available through traditional Medicare.

The government payment rate is critical for insurers as it directly determines:

• Monthly premium pricing
• Plan benefits offered
• Overall profitability

Official Statement

CMS Administrator Dr. Mehmet Oz stated the updates aim to "keep coverage affordable and ensure patients get real value from their plans."

Investor Implications

The substantial rate increase provides relief to major health insurers who depend heavily on Medicare Advantage revenue. The policy shift demonstrates a more favorable regulatory environment for the sector, potentially improving earnings outlooks for 2027 and beyond.